MarketCap US

US United States


iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.


iRhythm was founded in 2009 and is headquartered in San Francisco, California. The Company was founded by Dr. Ullas Naik, a veteran of the medical device industry, and his co-founder, Dr. David Rubin, Professor of Medicine at the University of California, San Francisco. In 2012, iRhythm created the Zio XT patch, an electronic monitoring patch that passively records and stores electrocardiogram (ECG) readings for 14 days.

To provide superior clinical service for patients.

Our vision is to continue to empower clinicians with actionable insights to provide better personalized arrhythmia care for patients.

Key Team

Mr. David A. Vort (Strategic Advisor)

Mr. Daniel G. Wilson (Exec. VP of Corp. Strategy)

Mr. Brice Bobzien CPA (Chief Financial Officer)

Dr. Mintu P. Turakhia M.D. (Chief Medical Officer & Chief Scientific Officer)

Mr. Patrick Michael Murphy J.D. (Chief Legal Officer)

Ms. Reyna M. Fernandez (Exec. VP & Chief HR Officer)

Mr. Mazi Kiani (Sr. VP of Quality & Regulatory)

Recognition and Awards
iRhythm has been recognized by numerous awards, including the 2019 Goldman Sachs 200 Investment as one of the best private companies in America and the 2018 Goldman Sachs 100 Investment for its innovation in healthcare. The company was also recognized as one of the most promising health technology companies in 2017 by Silicon Review.

Leadership team

Mr. Quentin S. Blackford (Pres, CEO & Director)

Mr. Douglas J. Devine (COO & Sec.)

Mr. Mark J. Day Ph.D. (Chief Technology Officer)

Products/ Services
Health Care, Health Diagnostics, Medical Device, mHealth, Wearables
Number of Employees
1,000 - 20,000
San Francisco, California, United States
Company Registration
SEC CIK number: 0001388658
100M - 500M
Traded as
Social Media
Fri Feb 23 2024

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with

Copyright 2023 © businessabc powered by ztudium